Lilly bolsters diagnostics presence with Avid acquisition
November 9, 2010Research and Development Alzheimer's disease, Alzheimer’s disease, Avid Radiopharma, Eli Lilly, diabetes, emagacestat, florbetapir, lilly
Eli Lilly has acquired specialist diagnostics firm Avid Radiopharma in a deal that will bolster its diagnostics business. Philadelphia-based Avid …
Novartis signs Middle East vaccine production deal
November 9, 2010Manufacturing and Production Agrippal, Arabio, Novartis, Quinvaxem, meningitis vaccine Menveo, vaccines
Novartis has forged an alliance with a Saudi Arabian manufacturer to help it expand its vaccines business in the Middle …
Cambrex buys Zenara to enter nicotine replacement market
November 9, 2010API, Cambrex, Cambrex Zenara, India, Pharmaceutical ingredients, Zenara Pharma, generic APIs, nicotine replacement
Pharmaceutical ingredient manufacturer Cambrex has taken a majority stake in Indian formulator Zenara Pharma for $20 million in a move …
Pharma manufacturing news in brief
November 9, 2010Manufacturing and Production Genentech, Hovione, Jacobs Engineering, Laureate Pharma, Recipharm, contract manufacturing, pharma manufacturing
Hovione wins a patent dispute, Genentech is awarded for a manufacturing plant and there are new contracts for Recipharm, Jacobs …
Late stage trial boost for Pfizer’s arthritis drug tasocitinib
November 8, 2010JAK inhibitors, Pfizer, arthritis, tasocitinib
Pfizer’s rheumatoid arthritis treatment tasocitinib has met its two of its three primary endpoints in a phase III trial. Primary …
Trial failure for Merck Serono’s Parkinson’s candidate
November 8, 2010Research and Development Merck Serono, Newron Pharmaceuticals, Parkinson's disease, dopamine agonists, levodopa, safinamide
Merck Serono’s new alpha-aminoamide safinamide has failed to reach its primary endpoint in a study with Parkinson’s disease patients. Merck …
Recycling pharma marketing research
November 8, 2010Medical Communications, Sales and Marketing Insight Marketing Systems, market research, marketing research, pharma marketing research
Recycling is in vogue. Not just in the consumer market, but across business sectors too. But recycling in the market …
GCI bags Novartis’ social media director
November 8, 2010Medical Communications GCI Health, Mark Davis, Novartis, appointment, medical communications
Novartis Pharmaceuticals’ former social media director Mark Davis has moved to GCI Health. He has been appointed to lead the …
NICE ‘surprised’ at downgrading of its role
November 5, 2010Sales and Marketing Andrew Dillon, GP prescribing deicisions, NICE, QALY, incremental cost-effectiveness ratio, value-based pricing
NICE received no warning that its health technology assessment role is to be downgraded, the watchdog’s head has admitted. In …
Roche’s melanoma candidate impresses in phase II trials
November 5, 2010Research and Development BRAF protein, Cancer, Phase II, Plexxikon, RG7204, Roche
Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …
Digital health and the Social Network
November 5, 2010Medical Communications Facebook, Red Door, The Social Network, digital pharma, social media
Followers of film will be only too aware that we are about to embark on ‘Oscar season’. Cinematic features are …
Bayer faces ABPI audit after “shocking” Levitra error
November 5, 2010Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Bayer, PMCPA
Bayer has been accused of a “shocking error of judgement” after promotional material for its erectile dysfunction brand Levitra (vardenafil) …
Danielle James and Kate Morrison join Virgo
November 5, 2010Medical Communications Danielle James, Kate Morrison, Virgo, Virgo Health PR, appointment, medical communications
Virgo Health has expanded its medical education and ethical health teams with two new appointments. Danielle James (pictured) has been …
Don’t replace NICE with another ‘misguided experiment’
November 5, 2010Sales and Marketing NHS, NICE, Stockholm Network, medicines access, risk-sharing
Replacing NICE with a similar system would be detrimental to UK healthcare, according to the Stockholm Network, which further warns …
Another US heparin recall for OSCS contamination
November 5, 2010Manufacturing and Production API, B. Braun Medical, heparin, manufacturing compliance, recalls
US pharmaceutical company B.
NicOx to halve HQ workforce
November 4, 2010Research and Development, Sales and Marketing NicOx, job cuts, naproxcinod, pharma jobs
French pharmaceutical company NicOx is to halve the workforce at its Sophia Antipolis headquarters and is considering restructuring its Italian …
Senior creative promotions at Woolley Pau
November 4, 2010Medical Communications Eric Houseknecht, Woolley Pau, Yvette Cumbers, appointment, medical communications
Woolley Pau has promoted senior copywriter Yvette Cumbers and senior art director Eric Houseknecht to the level of deputy creative …
Doctors.net.uk boosts business development team
November 4, 2010Sales and Marketing Doctors.net.uk, Jo Bell, Lizzie Evans, Paul Kelly, Phil Oldroyd, appointment, sales and marketing
Online healthcare professional network Doctors.net.uk has made three business development appointments and added a new project manager to its team. …
CME Spotlight: Making European CME work
November 4, 2010Medical Communications CME, CME Spotlight, Continuing medical education, Eugene Pozniak
Since spring I have been dealing with a team of builders who have missed every deadline possible, to the extent …
Biogen set to axe 650 jobs and focus on neurology
November 4, 2010Research and Development, Sales and Marketing Biogen, Rituxan, job cuts, pharma jobs
Biogen Idec is set to cut hundreds of jobs and refocus its R&D in an effort to cut costs by …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
